Bristol-Myers Squibb

49.23
-0.13 (-0.26%)
At close: Apr 17, 2025, 3:59 PM
49.49
0.54%
After-hours: Apr 17, 2025, 07:58 PM EDT

Bristol-Myers Squibb Statistics

Share Statistics

Bristol-Myers Squibb has 2.03B shares outstanding. The number of shares has increased by 0.38% in one year.

Shares Outstanding 2.03B
Shares Change (YoY) 0.38%
Shares Change (QoQ) 0.32%
Owned by Institutions (%) 78.38%
Shares Floating 2.03B
Failed to Deliver (FTD) Shares 2.38K
FTD / Avg. Volume 0.02%

Short Selling Information

The latest short interest is 29.4M, so 1.44% of the outstanding shares have been sold short.

Short Interest 29.4M
Short % of Shares Out 1.44%
Short % of Float 1.45%
Short Ratio (days to cover) 2.46

Valuation Ratios

The PE ratio is -12.81 and the forward PE ratio is 8.05. Bristol-Myers Squibb's PEG ratio is 0.06.

PE Ratio -12.81
Forward PE 8.05
PS Ratio 2.37
Forward PS 2.6
PB Ratio 7.02
P/FCF Ratio 8.22
PEG Ratio 0.06
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Bristol-Myers Squibb.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.25, with a Debt / Equity ratio of 3.13.

Current Ratio 1.25
Quick Ratio 1.15
Debt / Equity 3.13
Debt / EBITDA 16.16
Debt / FCF 3.67
Interest Coverage 3.02

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $1.42M
Profits Per Employee $-262.4K
Employee Count 34,100
Asset Turnover 0.52
Inventory Turnover 5.46

Taxes

Income Tax 554M
Effective Tax Rate -6.61%

Stock Price Statistics

The stock price has increased by 1.97% in the last 52 weeks. The beta is 0.41, so Bristol-Myers Squibb's price volatility has been higher than the market average.

Beta 0.41
52-Week Price Change 1.97%
50-Day Moving Average 57.3
200-Day Moving Average 53.65
Relative Strength Index (RSI) 25.86
Average Volume (20 Days) 12.84M

Income Statement

In the last 12 months, Bristol-Myers Squibb had revenue of 48.3B and earned -8.95B in profits. Earnings per share was -4.41.

Revenue 48.3B
Gross Profit 34.33B
Operating Income 5.89B
Net Income -8.95B
EBITDA 3.17B
EBIT -6.43B
Earnings Per Share (EPS) -4.41
Full Income Statement

Balance Sheet

The company has 10.35B in cash and 51.2B in debt, giving a net cash position of -40.85B.

Cash & Cash Equivalents 10.35B
Total Debt 51.2B
Net Cash -40.85B
Retained Earnings 14.91B
Total Assets 92.6B
Working Capital 6.01B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 15.19B and capital expenditures -1.25B, giving a free cash flow of 13.94B.

Operating Cash Flow 15.19B
Capital Expenditures -1.25B
Free Cash Flow 13.94B
FCF Per Share 6.88
Full Cash Flow Statement

Margins

Gross margin is 71.08%, with operating and profit margins of 12.19% and -18.53%.

Gross Margin 71.08%
Operating Margin 12.19%
Pretax Margin -17.35%
Profit Margin -18.53%
EBITDA Margin 6.56%
EBIT Margin 12.19%
FCF Margin 28.87%

Dividends & Yields

BMY pays an annual dividend of $3.04, which amounts to a dividend yield of 4.41%.

Dividend Per Share $3.04
Dividend Yield 4.41%
Dividend Growth (YoY) 3.33%
Payout Ratio -68.93%
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for BMY is $60, which is 21.8% higher than the current price. The consensus rating is "Hold".

Price Target $60
Price Target Difference 21.8%
Analyst Consensus Hold
Analyst Count 15
Stock Forecasts

Stock Splits

The last stock split was on Aug 7, 2001. It was a forward split with a ratio of 1000000:951777.

Last Split Date Aug 7, 2001
Split Type forward
Split Ratio 1000000:951777

Scores

Altman Z-Score 1.42
Piotroski F-Score 3